Zurich Cantonal Bank’s UroGen Pharma URGN Stock Holding History

Zurich Cantonal Bank’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$677K	Buy	18,398 +5,885	+47%	+$159K	﹤0.01%	1781
2026 Q1	$225K	Buy	+12,513	New	+$251K	﹤0.01%	2208
2025 Q1	–	Sell	-11,893	Closed	-$127K	–	2684
2024 Q4	$127K	Buy	+11,893	New	+$142K	﹤0.01%	2349
2022 Q2	–	Sell	-1,282	Closed	-$11K	–	2931
2022 Q1	$11K	Hold	1,282	–	–	﹤0.01%	2703
2021 Q4	$12K	Hold	1,282	–	–	﹤0.01%	2889
2021 Q3	$22K	Hold	1,282	–	–	﹤0.01%	2774
2021 Q2	$20K	Hold	1,282	–	–	﹤0.01%	2578
2021 Q1	$25K	Hold	1,282	–	–	﹤0.01%	2510
2020 Q4	$23K	Hold	1,282	–	–	﹤0.01%	2568
2020 Q3	$25K	Hold	1,282	–	–	﹤0.01%	2452
2020 Q2	$33K	Hold	1,282	–	–	﹤0.01%	2336
2020 Q1	$23K	Hold	1,282	–	–	﹤0.01%	2316
2019 Q4	$43K	Sell	1,282 -1,139	-47%	-$31.1K	﹤0.01%	2230
2019 Q3	$58K	Hold	2,421	–	–	﹤0.01%	1938
2019 Q2	$87K	Hold	2,421	–	–	﹤0.01%	1704
2019 Q1	$89K	Buy	2,421 +1,282	+113%	+$53.7K	﹤0.01%	1648
2018 Q4	$49K	Hold	1,139	–	–	﹤0.01%	2041
2018 Q3	$54K	Hold	1,139	–	–	﹤0.01%	2116
2018 Q2	$57K	Buy	+1,139	New	+$66.3K	﹤0.01%	2048

Other funds holding URGN

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Zurich Cantonal Bank's URGN Position: Q2 2026 in Review

Zurich Cantonal Bank increased its UroGen Pharma (URGN) stake by 47% in Q2 2026, buying an estimated $159K and bringing the position to 18,398 shares worth $677K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Zurich Cantonal Bank first reported a position in URGN in Q2 2018 and has held it in 19 quarters since. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

Zurich Cantonal Bank held 18,398 shares of UroGen Pharma worth $677K as of Q2 2026.
Zurich Cantonal Bank bought 5,885 UroGen Pharma shares in Q2 2026, an estimated $159K.
UroGen Pharma made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1781 holding.
Zurich Cantonal Bank first reported a position in UroGen Pharma in Q2 2018 and has held it in 19 quarters since.
189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.